연구성과로 돌아가기

2023 연구자 정보 (50 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Minh Tan Le
(Le, MT) ⓘ 		Kyungpook Natl Univ, Grad Sch, Dept Biomed Sci, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Combinatorial Optimization of Chemotherapeutic Agents on T-Cell Acute Lymphoblastic Leukemia ⓘ SCIE ⓘ 1.5 HEMATOLOGY ⓘ ⓘ
Nam, Hoseok
(Nam, H) ⓘ 		교신저자 Busan Res Inst, Pusan 47210, South Korea ⓘ MTF-8047-2025
Nam, Hoseok ⓘ
ⓘ 		[JCR상위 1.5] Experimental and numerical investigation on a solar-driven torrefaction reactor using woody waste (Ashe Juniper) ⓘ SCIE ⓘ 1.5 ENERGY & FUELS;MECHANICS;THERMODYNAMICS ⓘ namhs219@knu.ac.kr; ⓘ
Oh, H. -J.
(Oh, HJ) ⓘ 		제1저자 Chonnam Natl Univ, Sch Med, Jeonnam, South Korea
Hwasun Hosp, Jeonnam, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer Patients Treated with Durvalumab after Chemoradiotherapy ⓘ SCIE ⓘ 1.5 ONCOLOGY;RESPIRATORY SYSTEM ⓘ ⓘ
Oh, I. -J.
(Oh, IJ) ⓘ 		Chonnam Natl Univ, Sch Med, Jeonnam, South Korea
Hwasun Hosp, Jeonnam, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer Patients Treated with Durvalumab after Chemoradiotherapy ⓘ SCIE ⓘ 1.5 ONCOLOGY;RESPIRATORY SYSTEM ⓘ ⓘ
Oh, Jeeyoung
(Oh, J) ⓘ 		Konkuk Univ, Dept Neurol, Sch Med, Seoul, South Korea
Konkuk Univ, Sch Med, Dept Neurol, Med Ctr, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
[JCR상위 13.4] Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis ⓘ 		SCIE ⓘ 1.5 CLINICAL NEUROLOGY;PSYCHIATRY;SURGERY
CLINICAL NEUROLOGY ⓘ 		bjkim@skku.edu;sueh916@gmail.com;
paddy.waters@ndcn.ox.ac.uk;nrhong@gmail.com; ⓘ
Oh, Seong-il
(Oh, SI) ⓘ 		Inje Univ, Busan Paik Hosp, Dept Neurol, Coll Med, Busan, South Korea
Inje Univ, Busan Paik Hosp, Coll Med, Dept Neurol, Busan, South Korea ⓘ 		A-8790-2019
Oh, Seong-il ⓘ 		0000-0002-8067-2135
Oh, Seong-il ⓘ 		[JCR상위 1.5] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
[JCR상위 13.4] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum ⓘ 		SCIE ⓘ 1.5 CLINICAL NEUROLOGY;PSYCHIATRY;SURGERY
CLINICAL NEUROLOGY;NEUROSCIENCES ⓘ 		bjkim@skku.edu;sueh916@gmail.com; ⓘ
Oh, Sukjoong
(Oh, S) ⓘ 		Hanyang Univ, Med Ctr, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] A Single-Arm, Open-Label, Multicenter Study to Assess Molecular Response of P1101 Therapy in Patients with Polycythemia Vera and Elevated Hematocrit: Results from 12-Month Core Study ⓘ SCIE ⓘ 1.5 HEMATOLOGY ⓘ ⓘ
Park, C. -K.
(Park, CK) ⓘ 		Chonnam Natl Univ, Sch Med, Jeonnam, South Korea
Hwasun Hosp, Jeonnam, South Korea ⓘ 		AAT-9872-2021
Park, Cheol-Kyu ⓘ
ⓘ 		[JCR상위 1.5] Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer Patients Treated with Durvalumab after Chemoradiotherapy ⓘ SCIE ⓘ 1.5 ONCOLOGY;RESPIRATORY SYSTEM ⓘ ⓘ
Park, J. Y.
(Park, JY) ⓘ 		Kyungpook Natl Univ, Chilgok Hosp, Dept Internal Med, Daegu, South Korea
Hallym Univ, Dept Internal Med, Sacred Heart Hosp, Anyang, South Korea
Chung Ang Univ Hosp, Dept Paediat, Seoul, South Korea ⓘ 		ABB-2937-2021
KDO-4256-2024
Park, Sun
Park, Ji Young ⓘ 		0000-0002-6777-0494
Park, Ji Young ⓘ 		[JCR상위 1.5] Comparison of etoposide/cisplatin and irinotecan/cisplatin for extensive-stage small cell lung cancer in Koreans: A real-world retrospective observational study
[JCR상위 1.1] Enhancing lung nodule discrimination with a novel cfDNA test: The cancer signature ensemble (CSE) approach
[JCR상위 14.8] Appropriateness of antibiotic use for patients with asymptomatic bacteriuria or urinary tract infection with positive urine culture: a retrospective observational multi-centre study in Korea ⓘ 		SCIE ⓘ 1.1 ONCOLOGY;RESPIRATORY SYSTEM
ONCOLOGY
INFECTIOUS DISEASES;PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH ⓘ 		hbkimmd@snu.ac.kr; ⓘ
Park, Joon Seong
(Park, JS) ⓘ 		Ajou Univ, Sch Med, Dept Hematol Oncol, Suwon, South Korea
Ajou Univ, Dept Hematol Oncol, Sch Med, Suwon, South Korea ⓘ 		CZZ-0090-2022
Park, Jung Hoon ⓘ
ⓘ 		[JCR상위 1.5] A Single-Arm, Open-Label, Multicenter Study to Assess Molecular Response of P1101 Therapy in Patients with Polycythemia Vera and Elevated Hematocrit: Results from 12-Month Core Study
[JCR상위 4.6] Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation ⓘ 		SCIE ⓘ 1.5 HEMATOLOGY
HEMATOLOGY;ONCOLOGY ⓘ 		sksohn@knu.ac.kr; ⓘ
Park, Kyung Seok
(Park, KS) ⓘ 		Seoul Natl Univ, Dept Neurol, Bundang Hosp, Seongnam, South Korea
Seoul Natl Univ, Bundang Hosp, Dept Neurol, Bundang, South Korea ⓘ 		J-5472-2012
Park, Kyung ⓘ
ⓘ 		[JCR상위 1.5] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
[JCR상위 13.4] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum ⓘ 		SCIE ⓘ 1.5 CLINICAL NEUROLOGY;PSYCHIATRY;SURGERY
CLINICAL NEUROLOGY;NEUROSCIENCES ⓘ 		bjkim@skku.edu;sueh916@gmail.com; ⓘ
Park, Su Yeon
(Park, SY) ⓘ 		제1저자 Korea Canc Ctr Hosp, Dept Neurol, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
[JCR상위 13.4] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum ⓘ 		SCIE ⓘ 1.5 CLINICAL NEUROLOGY;PSYCHIATRY;SURGERY
CLINICAL NEUROLOGY;NEUROSCIENCES ⓘ 		bjkim@skku.edu;sueh916@gmail.com; ⓘ
Park, Yong
(Park, Y) ⓘ 		Korea Univ, Coll Med, Dept Internal Med, Seoul, South Korea
Korea Univ, Dept Internal Med, Coll Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] A Single-Arm, Open-Label, Multicenter Study to Assess Molecular Response of P1101 Therapy in Patients with Polycythemia Vera and Elevated Hematocrit: Results from 12-Month Core Study
[JCR상위 1.5] The Co-Occurrence of bZIP in-Frame CEBPA-Mutation with Unfavorable Genetic Abnormalities Is Associated with a Poor Prognosis in Acute Myeloid Leukemia ⓘ 		SCIE ⓘ 1.5 HEMATOLOGY ⓘ ⓘ
Rice, William G.
(Rice, WG) ⓘ 		Aptose Biosci, San Diego, CA USA ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Tuspetinib Myeloid Kinase Inhibitor Safety and Efficacy As Monotherapy and Combined with Venetoclax in Phase 1/2 Trial of Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) ⓘ SCIE ⓘ 1.5 HEMATOLOGY ⓘ ⓘ
Rodriguez-Alejandro, David Aaron
(Rodríguez-Alejandro, DA) ⓘ 		제1저자 Univ Guanajuato, Salamanca 36885, Gto, Mexico
Texas A&M Univ, College Stn, TX 77843 USA ⓘ 		JHU-0787-2023
RODRIGUEZ-ALEJANDRO, DAVID ⓘ 		0000-0001-7033-0230
RODRIGUEZ-ALEJANDRO, DAVID AARON ⓘ 		[JCR상위 1.5] Experimental and numerical investigation on a solar-driven torrefaction reactor using woody waste (Ashe Juniper) ⓘ SCIE ⓘ 1.5 ENERGY & FUELS;MECHANICS;THERMODYNAMICS ⓘ namhs219@knu.ac.kr; ⓘ
페이지 이동: